News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genetic Immunity Presents the DermaPrep Transdermal Delivery System and DermaVir Nanomedicine-based Therapeutic Vaccine for HIV/AIDS at HIV DART 2010 Drug Development Conference



12/9/2010 8:39:08 AM

BUDAPEST, Hungary & MCLEAN, Va.--(BUSINESS WIRE)--Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine vaccines, will present data at this week’s HIV DART 2010 conference, “Frontiers in Drug Development for Antiretroviral Therapies,” in Los Cabos, Mexico. The conference brings international researchers together to discuss the latest developments in the fight against HIV/AIDS.

Read at BioSpace.com

Related News

comments powered by Disqus
   
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES